Sexual dysfunction and hyperprolactinemia in male psychotic inpatients: A cross-sectional study

Advances in Urology

Volumn , Issue , 2011, Pages

  Johnsen, Erik ^a,b   Kroken, Rune ^a   Løberg, Else Marie ^a,b   Kjelby, Eirik ^a   Jørgensen, Hugo A ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855703278     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2011/686924     Document Type: Article

References (26)

1. stn T. B., Rehm J., Chatterji S., Multiple-informant ranking of the disabling effects of different health conditions in 14 countries The Lancet 1999 354 111 115 (Pubitemid 29313145)
2. Perl J., Suvisaari J., Saarni S. I., Lifetime prevalence of psychotic and bipolar I disorders in a general population Archives of General Psychiatry 2007 64 19 28 (Pubitemid 46041735)
3. Leucht S., Corves C., Arbter D., Engel R. R., Li C., Davis J. M., Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis The Lancet 2009 373 9657 31 41
4. Crossley N. A., Constante M., McGuire P., Power P., Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis The British Journal of Psychiatry 2010 196 6 434 439
5. Perkins D. O., Predictors of noncompliance in patients with schizophrenia Journal of Clinical Psychiatry 2002 63 12 1121 1128 (Pubitemid 36084056)
6. Lambert M., Conus P., Eide P., Mass R., Karow A., Moritz S., Golks D., Naber D., Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence European Psychiatry 2004 19 7 415 422 (Pubitemid 39422495)
7. Byerly M., Suppes T., Tran Q. V., Baker R. A., Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives Journal of Clinical Psychopharmacology 2007 27 6 639 661 (Pubitemid 351339452)
8. Haddad P. M., Wieck A., Antipsychotic-induced hyperprolactinaemia. Mechanisms, clinical features and management Drugs 2004 64 20 2291 2314 (Pubitemid 39388605)
9. Olfson M., Uttaro T., Carson W. H., Tafesse E., Male sexual dysfunction and quality of life in schizophrenia Journal of Clinical Psychiatry 2005 66 3 531 538
10. Johnsen E., Kroken R. A., Wentzel-Larsen T., Jrgensen H. A., Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone BMC Psychiatry 2010 10, article 26
11. Kay S. R., Fiszbein A., Opler L. A., The positive and negative syndrome scale (PANSS) for schizophrenia Schizophrenia Bulletin 1987 13 2 261 276 (Pubitemid 18039085)
12. World Health Organization, International statistical classification of diseases and related health problems. 10th Revision, version for 2007. World Health Organization/German Institute of Medical Documentation and Information, 19942006 http://www.who.int/classifications/apps/icd/icd10online/
13. Addington D., Addington J., Schissel B., A depression rating scale for schizophrenics Schizophrenia Research 1990 3 4 247 251 (Pubitemid 20228720)
14. Drake R. E., Rosenberg S. D., Mueser K. T., Assessing substance use disorder in persons with severe mental illness New Directions for Mental Health Services 1996 70 3 17
15. Guy W., EDDEU Assessment Manual for Psychopharmacology Revisited (DHHS publ NO ADM 91338) 1976 Rockville, Md, USA US Department of Health and Human Services
16. Karterud S., Pedersen G., Loevdahl H., Friis S., Global Assessment of FunctioningSplit Version (S-GAF): Background and Scoring Manual 1998 Oslo, Norway Ullevaal University Hospital, Department of Psychiatry
17. Randolph C., Tierney M. C., Mohr E., Chase T. N., The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity Journal of Clinical and Experimental Neuropsychology 1998 20 3 310 319 (Pubitemid 28539551)
18. Lindstrm E., Lewander T., Malm U., Malt U. F., Lublin H., Ahlfors U. G., Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat) Nordic Journal of Psychiatry, Supplement 2001 55 supplement 44 5 69
19. Dossenbach M., Hodge A., Anders M., Molnr B., Peciukaitiene D., Krupka-Matuszczyk I., Tatu M., Bondar V., Pecenak J., Gorjanc T., McBride M., Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation International Journal of Neuropsychopharmacology 2005 8 2 195 201 (Pubitemid 40769260)
20. Ronning M., The WHO collaborating centre for drug statistics methodology. Established 1982 http://www.whocc.no/atcddd/
21. Obradovic M., Mrhar A., Kos M., Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia International Journal of Clinical Practice 2007 61 12 1979 1988 (Pubitemid 350077391)
22. Bobes J., Garca-Portilla M. P., Rejas J., Hernndez G., Garcia-Garcia M., Rico-Villademoros F., Porras A., Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study Journal of Sex and Marital Therapy 2003 29 2 125 147 (Pubitemid 36278732)
23. Johnsen E., Kroken R. A., Abaza M., Olberg H., Jrgensen H. A., Antipsychotic-induced hyperprolactinemia: a cross-sectional survey Journal of Clinical Psychopharmacology 2008 28 6 686 690
24. Rettenbacher M. A., Hofer A., Ebenbichler C., Baumgartner S., Edlinger M., Engl J., Kaser S., Kemmler G., Malik P., Tschoner A., Fleischhacker W. W., Prolactin levels and sexual adverse effects in patients with schizophrenia during antipsychotic treatment Journal of Clinical Psychopharmacology 2010 30 6 711 715
25. Nakonezny P. A., Byerly M. J., Rush A. J., The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine Journal of Sex and Marital Therapy 2007 33 3 203 216 (Pubitemid 46535723)
26. Malik P., Kemmler G., Hummer M., Riecher-Roessler A., Kahn R. S., Fleischhacker W. W., SD in first-episode schizophrenia patients. Results from Europeand First Episode Schizophrenia Trial Journal of Clinical Psychopharmacology 2011 31 274 280